| |
|
|
|
Immucell Cp  
|
|
5.71 0.03 (0.01%) |
10-23 16:00 |
|
Open: |
5.7 |
Pre close: |
5.68 |
Target:
|
7.46 
|
|
High: |
5.96 |
Low: |
5.63 |
Resistance:
|
6.39
7.46
|
|
Volume: |
1,078 |
Market Cap: |
41M |
Support:
|
5.54
5.01
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.81
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
5.68 |
Signal(12,26,9): |
0.09 |
|
MA(100): |
5.38 |
Stochastic Oscillator |
%K(14,3):
|
35.58 |
|
MA(250): |
5.03 |
%D(3): |
43.33 |
|
Average Volume(K) |
3-Month: |
1077
|
52-Week |
High:
|
8.13 |
|
10-Days: |
1603 |
Low: |
3.70 |
|
RSI |
RSI(14):
|
52.24 |
Change(%): |
11.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.240 |
Return on Equity (ttm) |
-5.9 |
Shares Out. (M) |
7.21 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-1.8 |
Shares Float (M) |
5.16 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
9.4 |
% Held by Institutions |
20.36 |
|
Forward EPS |
-0.030 |
Gross Profit (p.s.) |
0.935 |
Shares Short (K) |
17 |
|
Book Value (p.s.) |
3.920 |
EBITDA (p.s.) |
0.153 |
P/E |
-23.79 |
|
Sales Per Share |
2.008 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.46 |
|
Profit Margin |
-11.75 |
Operating Cash Flow
(M) |
1.71 |
P/S |
2.84 |
|
Operating Margin |
-8.06 |
Levered Free Cash Flow
(M) |
-0.54 |
P/CF |
24.08 |
|
|
|
|
|
|
